Galectin 9 anticorps (AA 51-150)
-
- Antigène Voir toutes Galectin 9 (LGALS9) Anticorps
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
-
Épitope
- AA 51-150
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Galectin 9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Réactivité croisée
- Humain, Souris
- Homologie
- Rat,Cow,Pig
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from mouse Galectin
- Isotype
- IgG
- Top Product
- Discover our top product LGALS9 Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IF(IHC-F) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
-
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. ..." dans: Nature medicine, Vol. 23, Issue 5, pp. 556-567, (2017) (PubMed).
: "
-
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. ..." dans: Nature medicine, Vol. 23, Issue 5, pp. 556-567, (2017) (PubMed).
-
- Antigène
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
- Autre désignation
- Galectin 9 (LGALS9 Produits)
- Synonymes
- anticorps huat, anticorps lgals9a, anticorps ecalectin, anticorps galectin-9, anticorps Lgals9, anticorps wu:fd20c09, anticorps zgc:111833, anticorps LGALS9, anticorps AA407335, anticorps AI194909, anticorps AI265545, anticorps LGALS35, anticorps Lgals5, anticorps gal-9, anticorps HUAT, anticorps LGALS9A, anticorps UAT, anticorps UATP.I, anticorps galectin 9 L homeolog, anticorps galectin 9, anticorps lectin, galactoside-binding, soluble, 9 (galectin 9)-like 3, anticorps lectin, galactose binding, soluble 9, anticorps lgals9.L, anticorps lgals9, anticorps lgals9l3, anticorps LGALS9, anticorps Lgals9
- Sujet
-
Synonyms: Ecalectin, galectin9, HOM HD 21, HOMHD21, HUAT, Lectin galactoside binding soluble 9, LGAL S9, LGALS 9, LGALS9, LGALS9A, MGC117375, MGC125973, MGC125974 , Urate transporter/channel protein, Galectin-9, Gal-9.
Background: The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin 9 is an S-type lectin and an eosinophil chemoattractant (ECA) produced by antigen-activated T cells. Galectin 9 is involved in apoptosis, is thought to be a prognostic factor for breast cancer and is also overexpressed in Hodgkin's disease tissue. The protein has N- and C- terminal carbohydrate-binding domains connected by a link peptide. Multiple alternatively spliced transcript variants have been found for this gene.
- ID gène
- 3965
-